STBT5:Inflammatory myofibroblastic tumour: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
[[STBT5:Table_of_Contents|Soft Tissue and Bone Tumours (Who Classification, 5th ed.)]] | [[STBT5:Table_of_Contents|Soft Tissue and Bone Tumours (Who Classification, 5th ed.)]] | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
Katherine Geiersbach, MD, Mayo Clinic - Rochester, MN, USA | Katherine Geiersbach, MD, Mayo Clinic - Rochester, MN, USA | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
| Line 180: | Line 180: | ||
None | None | ||
==Additional Information== | ==Additional Information== | ||
None | |||
==Links== | ==Links== | ||
None | None | ||